Omzo vs JoinFridays: Clinician-Guided Compounds Compared
Short verdict: Omzo emphasizes clinician-guided, personalized compounded semaglutide and tirzepatide care with prices starting at $179, while JoinFridays focuses on lower starting monthly pricing and flexible cancel-anytime terms starting at $117/month. This comparison highlights the key differences so you can decide which model fits your needs.
Explore Omzo clinician-guided plans
Omzo vs JoinFridays: pricing and membership
Price structure is a leading difference. Omzo lists semaglutide starting at $179 and tirzepatide starting at $279. JoinFridays advertises programs starting at $117/month, with standalone monthly plans and multi-month plans that lower the effective rate; JoinFridays emphasizes no membership fees and cancel anytime.
See JoinFridays pricing and cancel-anytime terms
Medication options and how they are delivered
Both platforms offer clinician-guided GLP-1 care and access to compounded semaglutide and tirzepatide, but they present the options differently. Omzo connects patients with licensed U.S. providers who may prescribe either compounded medications or write prescriptions for branded medications that patients must fill themselves. JoinFridays offers compounded tirzepatide and semaglutide on its platform and also lists name-brand options with insurance support for separate pricing tiers.
Five-point comparison table
| Criteria | Omzo | JoinFridays |
|---|---|---|
| Starting price | Semaglutide starting at $179 | Starting at $117/month |
| Medication types | Compounded semaglutide & tirzepatide; prescriptions for branded meds possible | Compounded semaglutide & tirzepatide; name-brand options listed |
| Clinician guidance | Clinician-guided plans reviewed by licensed U.S. providers | Personalized clinician-guided care with dosing guidance |
| Membership / cancellation | Pricing and terms may vary; confirm renewal and state availability before enrolling | No membership fees; cancel anytime; multi-month plans reduce effective rate |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
Difference 1: Upfront cost model
Omzo presents per-program starting prices such as semaglutide starting at $179 and tirzepatide starting at $279. JoinFridays emphasizes a monthly pricing model with a lowest advertised entry point of $117/month and explicit multi-month pricing that lowers the average monthly cost. If you prioritize a lower advertised monthly entry price, JoinFridays markets that advantage; Omzo lists per-treatment starting fees.
Compare Omzo program starting prices
Difference 2: Flexibility and commitments
JoinFridays explicitly states no long-term contracts, no membership fees, and the ability to cancel anytime. Omzo’s materials advise confirming eligibility, total cost, renewal terms, and state availability before enrollment, indicating terms and availability may change and that patients should verify specifics before starting.
Difference 3: How compounded and branded options are handled
Omzo describes a model where clinical providers may use a compounded medication program or alternatively write a prescription for branded medications; Omzo does not sell or ship branded drugs and patients fill prescriptions themselves. JoinFridays lists both compounded programs and name-brand options as distinct pricing tiers and notes insurance support for name-brand choices. Both sources include the qualifier that compounded medications are not FDA-approved.
Difference 4: Pricing transparency and promos
JoinFridays advertises active promo codes and specific savings ranges in captured content, and details promo codes such as NEWYOU12 and NYNY12 in its FAQ. Omzo emphasizes clinician-guided care and lists starting prices without captured promo-code details in the supplied evidence.
What the regulatory notes mean for both
Both sources clearly state that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Omzo explicitly states its compounded drugs are prepared by a state-licensed sterile compounding pharmacy and are not FDA-approved. JoinFridays includes the same regulatory qualifier for compounded medications.
Final thoughts on Omzo vs JoinFridays
Omzo centers on clinician-reviewed programs with quoted starting prices such as semaglutide starting at $179 and an option for providers to prescribe branded medications that patients then fill. JoinFridays competes on lower entry pricing, a monthly model starting at $117/month, no long-term contracts, and aggressive promo codes on compounded tirzepatide and semaglutide. Both platforms rely on licensed clinicians and both note that compounded medications are not FDA-approved.
Check JoinFridays plans and promo availability
Review Omzo clinician-guided GLP-1 care
Choose Omzo if…
you want clinician-guided programs reviewed by licensed U.S. providers with quoted starting prices such as semaglutide starting at $179 and you value a model where providers may prescribe branded medications separately.
Choose JoinFridays if…
you prioritize the lowest advertised starting monthly price and flexible cancellation terms, want compounded tirzepatide and semaglutide options from $117/month, and may benefit from active promo codes and multi-month pricing that lowers effective cost.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →